Experienced in Tetanus

Nancy Levin-Agmon

Tel Aviv, TA, IL 
Experienced in Tetanus
Tel Aviv, TA, IL 
OverviewLocationsClinical Research

Overview

Nancy Levin-Agmon practices in Tel Aviv, Israel. Ms. Levin-Agmon is rated as an Experienced expert by MediFind in the treatment of Tetanus. Her top areas of expertise are Angioedema, Hives, Antiphospholipid Syndrome, and Systemic Lupus Erythematosus (SLE).

Her clinical research consists of co-authoring 177 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Tetanus.

Gender
Female

Locations

Tel Aviv, TA, Israel
Other Locations
Ramat Gan, TA, Israel
Tel Litwinsky, TA, Israel
Ramat Aviv, TA, Israel
Israel
Rehovot, M, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Three-year, Non-interventional, Prospective, Multicenter Study to Evaluate the Long- Term Effectiveness of Lanadelumab in Real-world Clinical Practice (ENABLE)
A Three-year, Non-interventional, Prospective, Multicenter Study to Evaluate the Long- Term Effectiveness of Lanadelumab in Real-world Clinical Practice (ENABLE)
Enrollment Status: Completed
Publish Date: September 02, 2025
Icatibant Outcome Survey (IOS) Registry
Icatibant Outcome Survey (IOS) Registry
Enrollment Status: Completed
Publish Date: October 28, 2024
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 3 Less Clinical Trials

177 Total Publications

Navigating Fertility Challenges: A Case Report on Immune Thrombocytopenia and Antiphospholipid Antibodies in a Woman Pursuing Pregnancy.
Navigating Fertility Challenges: A Case Report on Immune Thrombocytopenia and Antiphospholipid Antibodies in a Woman Pursuing Pregnancy.
Journal: The Israel Medical Association journal : IMAJ
Published: September 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Levin-Agmon's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 50 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile